Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Ptc Therapeutics (PTCT) Preferred Stock Liabilities: 2011-2012

Historic Preferred Stock Liabilities for Ptc Therapeutics (PTCT) over the last 2 years, with Dec 2012 value amounting to $80.8 million.

  • Ptc Therapeutics' Preferred Stock Liabilities was N/A to $80.8 million in Q4 2012 from the same period last year, while for Dec 2012 it was $80.8 million, marking a year-over-year change of. This contributed to the annual value of $80.8 million for FY2012, which is 62.30% down from last year.
  • According to the latest figures from FY2012, Ptc Therapeutics' Preferred Stock Liabilities is $80.8 million, which was down 62.30% from $214.4 million recorded in FY2011.
  • Over the past 5 years, Ptc Therapeutics' Preferred Stock Liabilities peaked at $214.4 million during FY2011, and registered a low of $80.8 million during FY2012.
  • Moreover, its 2-year median value for Preferred Stock Liabilities was $147.6 million (2011), whereas its average is $147.6 million.
  • Data for Ptc Therapeutics' Preferred Stock Liabilities shows a maximum YoY plummeted of 62.30% (in 2012) over the last 5 years.
  • Yearly analysis of 2 years shows Ptc Therapeutics' Preferred Stock Liabilities stood at $214.4 million in 2011, then plummeted by 62.30% to $80.8 million in 2012.